Adient (ADNT) was Initiated by Morgan Stanley to “Overweight” and the brokerage firm has set the Price Target at $95. Morgan Stanley advised their Clients and Investors in a research report released on Feb 21, 2017.
Based on several research reports , Company shares were Reiterated by RBC Capital Mkts on Feb 6, 2017 to “Outperform”, Firm has raised the Price Target to $ 85 from a previous price target of $73 .Susquehanna Initiated Adient on Nov 28, 2016 to “Neutral”, Price Target of the shares are set at $56.
On the company’s financial health, Adient reported $2.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Feb 3, 2017. Analyst had a consensus of $2.06. The company had revenue of $4038.00 million for the quarter, compared to analysts expectations of $4225.40 million. The company’s revenue was down -4.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.87 EPS.
Adient closed down -0.69 points or -1.07% at $64.01 with 6,70,078 shares getting traded on Friday. Post opening the session at $64.19, the shares hit an intraday low of $63.85 and an intraday high of $64.7 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.